MDXG
MiMedx Group, Inc. Healthcare - Biotechnology Investor Relations →
MiMedx Group, Inc. (MDXG) closed at $5.15 as of 2026-02-02, trading 16.6% below its 200-week moving average of $6.17. This places MDXG in the extreme value zone. The stock moved further from the line this week, up from -17.2% last week. With a 14-week RSI of 14, MDXG is in oversold territory.
Over the past 890 weeks of data, MDXG has crossed below its 200-week moving average 15 times. On average, these episodes lasted 29 weeks. Historically, investors who bought MDXG at the start of these episodes saw an average one-year return of +11.6%.
With a market cap of $763 million, MDXG is a small-cap stock. The company generates a free cash flow yield of 6.8%, which is healthy. Return on equity stands at 19.4%, a solid level. The stock trades at 3.2x book value.
Share count has increased 31.3% over three years, indicating dilution. MDXG passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 17.2 years, a hypothetical investment of $100 in MDXG would have grown to $286, compared to $1137 for the S&P 500. MDXG has returned 6.3% annualized vs 15.2% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 1 open-market purchase totaling $1,268,000. Notably, these purchases occurred while MDXG is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: MDXG vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After MDXG Crosses Below the Line?
Across 14 historical episodes, buying MDXG when it crossed below its 200-week moving average produced an average return of +11.7% after 12 months (median +2.0%), compared to +13.7% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was -14.1% vs +29.6% for the index.
Each line shows $100 invested at the moment MDXG crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
MDXG has crossed below its 200-week MA 15 times with an average 1-year return of +11.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 2009 | Jun 2012 | 176 | 90.3% | -58.8% | +106.0% |
| May 2016 | May 2016 | 3 | 5.5% | +98.7% | -27.4% |
| Aug 2016 | Sep 2016 | 3 | 3.6% | +126.3% | -29.5% |
| Jan 2017 | Feb 2017 | 1 | 3.1% | +107.1% | -33.9% |
| Feb 2017 | Feb 2017 | 1 | 1.4% | -1.8% | -35.4% |
| Feb 2018 | Dec 2020 | 147 | 87.7% | -59.8% | -34.2% |
| Sep 2021 | Oct 2021 | 4 | 12.1% | -47.0% | -16.3% |
| Dec 2021 | Jun 2023 | 77 | 54.8% | -54.0% | -14.7% |
| Oct 2023 | Nov 2023 | 4 | 5.2% | -4.3% | -15.3% |
| Apr 2024 | Apr 2024 | 3 | 5.1% | +6.2% | -20.0% |
| Jul 2024 | Aug 2024 | 3 | 6.4% | +10.8% | -20.3% |
| Sep 2024 | Oct 2024 | 8 | 14.6% | +16.1% | -16.3% |
| Apr 2025 | May 2025 | 1 | 0.7% | N/A | -18.5% |
| Jun 2025 | Jun 2025 | 3 | 5.9% | N/A | -14.7% |
| Jan 2026 | Ongoing | 5+ | 17.2% | Ongoing | -15.6% |
| Average | 29 | — | +11.6% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02